Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACE-BRIDGE: Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Stroke
NCT07748039Phase 3Recruiting
- Sponsor
- Yongjun Wang
- Start
- Oct 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase, reteplase in ischemic stroke, sponsored by Yongjun Wang. Started Oct 2026; status: recruiting.
02
Drugs
tenecteplasereteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07748039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07748039.